Literature DB >> 10785449

Molecular dating of senile plaques in the brains of individuals with Down syndrome and in aged dogs.

B Y Azizeh1, E Head, M A Ibrahim, R Torp, A J Tenner, R C Kim, I T Lott, C W Cotman.   

Abstract

beta-Amyloid (Abeta) is a constituent of senile plaques found with increasing age in individuals with Down syndrome (DS) and in the canine model of aging. Sections of DS and dog brain were immunostained using an affinity-purified polyclonal antibody for a posttranslationally modified Abeta with a racemized aspartate at position 7 (d7C16). The immunostaining characteristics of d7C16 Abeta in DS and dog brain indicate that it is present in all plaque subtypes, including the thioflavin-S-negative diffuse plaques that develop with age in dogs. The youngest DS case exhibited weak immunolabeling for d7C16 but the extent of d7C16-positive plaques increased with age. In addition, d7C16-positive plaques were initially found in clusters in the superficial layers of the frontal and entorhinal cortex but, with advancing age, increasing numbers appeared in deeper layers, suggesting a progression of Abeta deposition from superficial to deeper cortical layers. Ultrastructural studies in DS brain were confirmed using perfused dog brain and provided consistent results; thioflavin-S-negative diffuse plaques consist of fibrillar Abeta and racemized Abeta is associated with thicker and more highly interwoven fibrils than nonracemized Abeta. The use of antibodies to modified forms of the Abeta protein should provide insight into the progression of plaque pathology in DS and Alzheimer's disease brain. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10785449     DOI: 10.1006/exnr.2000.7359

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  13 in total

1.  Event-related potential index of age-related differences in memory processes in adults with Down syndrome.

Authors:  Alexandra P Key; Elisabeth M Dykens
Journal:  Neurobiol Aging       Date:  2013-08-29       Impact factor: 4.673

2.  Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.

Authors:  Giovanna Cenini; Amy L S Dowling; Tina L Beckett; Eugenio Barone; Cesare Mancuso; Michael Paul Murphy; Harry Levine; Ira T Lott; Frederick A Schmitt; D Allan Butterfield; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2011-10-08

3.  Aβ vaccination in combination with behavioral enrichment in aged beagles: effects on cognition, Aβ, and microhemorrhages.

Authors:  Paulina R Davis; Ginevra Giannini; Karin Rudolph; Nathaniel Calloway; Christopher M Royer; Tina L Beckett; M Paul Murphy; Frederick Bresch; Dieter Pagani; Thomas Platt; Xiaohong Wang; Amy Skinner Donovan; Tiffany L Sudduth; Wenjie Lou; Erin Abner; Richard Kryscio; Donna M Wilcock; Edward G Barrett; Elizabeth Head
Journal:  Neurobiol Aging       Date:  2016-09-26       Impact factor: 4.673

4.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

Review 5.  Down syndrome, beta-amyloid and neuroimaging.

Authors:  Elizabeth Head; Alex M Helman; David Powell; Frederick A Schmitt
Journal:  Free Radic Biol Med       Date:  2017-09-19       Impact factor: 7.376

6.  Neurobiology of the aging dog.

Authors:  Elizabeth Head
Journal:  Age (Dordr)       Date:  2010-09-16

Review 7.  Neurological phenotypes for Down syndrome across the life span.

Authors:  Ira T Lott
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 8.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

9.  Nerve growth factor metabolic dysfunction in Down's syndrome brains.

Authors:  M Florencia Iulita; Sonia Do Carmo; Alison K Ower; Ashley M Fortress; Lisi Flores Aguilar; Michael Hanna; Thomas Wisniewski; Ann-Charlotte Granholm; Mona Buhusi; Jorge Busciglio; A Claudio Cuello
Journal:  Brain       Date:  2014-02-11       Impact factor: 13.501

Review 10.  Dementia in Down syndrome: unique insights for Alzheimer disease research.

Authors:  Ira T Lott; Elizabeth Head
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.